FGF2 stimulates COUP-TFII expression via the MEK1/2 pathway to inhibit osteoblast differentiation in C3H10T1/2 cells

PLoS ONE

Volumn 11, Issue 7, 2016, Pages

  Lee, Mi Nam ^a   Kim, Jung Woo ^a   Oh, Sin Hye ^a   Jeong, Byung Chul ^a   Hwang, Yun Chan ^a   Koh, Jeong Tae ^a  

^a Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; SMALL INTERFERING RNA; MAP2K2 PROTEIN, MOUSE;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC MARKER; MESENCHYME CELL; OSTEOBLAST; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; 3T3 CELL LINE; ANIMAL; BONE DEVELOPMENT; CYTOLOGY; DRUG EFFECTS; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; TIME FACTOR;

3T3 CELLS; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; COUP TRANSCRIPTION FACTOR II; EXTRACELLULAR SPACE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STROMAL CELLS; MICE; OSTEOBLASTS; OSTEOGENESIS; TIME FACTORS;

EID: 84978924096     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0159234     Document Type: Article

References (46)

1. Tsai SY, Tsai M-J. Chick Ovalbumin Upstream Promoter-Transcription Factors (COUP-TFs): Coming of Age. Endocr Rev. 1997; 18(2):229-40. doi: 10.1210/edrv.18.2.0294 PMID: 9101138
2. Pereira FA, Qiu Y, Zhou G, Tsai M-J, Tsai SY. The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Gene Dev. 1999; 13(8):1037-49. PMID: 10215630; PubMed Central PMCID: PMCPMC316637.
3. Xie X, Qin J, Lin S-H, Tsai SY, Tsai M-J. Nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) modulates mesenchymal cell commitment and differentiation. Proc Natl Acad Sci USA. 2011; 108(36):14843-8. doi: 10.1073/pnas.1110236108 PMID: 21873211; PubMed Central PMCID: PMCPMC3169151
4. Lee K-N, Jang W-G, Kim E-J, Oh S-H, Son H-J, Kim S-H, et al. Orphan Nuclear Receptor Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII) Protein Negatively Regulates Bone Morphogenetic Protein 2-induced Osteoblast Differentiation through Suppressing Runt-related Gene 2 (Runx2) Activity. J Biol Chem. 2012; 287(23):18888-99. doi: 10.1074/jbc.M111.311878 PMID: 22493443; PubMed Central PMCID: PMCPMC3365924
5. Xu Z, Yu S, Hsu C-H, Eguchi J, Rosen ED. The orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II is a critical regulator of adipogenesis. Proc Natl Acad Sci USA. 2008; 105(7):2421-6. doi: 10.1073/pnas.0707082105 PMID: 18250317 PubMed Central PMCID: PMCPMC2268152.
6. Okamura M, Kudo H, Wakabayashi K-i, Tanaka T, Nonaka A, Uchida A, et al. COUP-TFII acts downstream of Wnt/β-catenin signal to silence PPARγ gene expression and repress adipogenesis. Proc Natl Acad Sci USA. 2009; 106(14):5819-24. doi: 10.1073/pnas.0901676106 PMID: 19307559; PubMed Central PMCID: PMCPMC2667001
7. Jeong BC, Kang IH, Hwang YC, Kim SH, Koh JT. MicroRNA-194 reciprocally stimulates osteogenesis and inhibits adipogenesis via regulating COUP-TFII expression. Cell Death Dis. 2014; 5:e1532. doi: 10.1038/cddis.2014.485 PMID: 25412310; PubMed Central PMCID: PMCPMC4260743
8. Kang I-H, Jeong B-C, Hur S-W, Choi H, Choi S-H, Ryu J-H, et al. MicroRNA-302a Stimulates Osteoblastic Differentiation by Repressing COUP-TFII Expression. J Cell Physiol. 2015; 230(4):911-21. doi: 10.1002/jcp.24822 PMID: 25215426
9. Satija NK, Gurudutta GU, Sharma S, Afrin F, Gupta P, Verma YK, et al. Mesenchymal Stem Cells: Molecular Targets for Tissue Engineering. Stem Cells Dev. 2007; 16(1):7-24. doi: 10.1089/scd.2006.9998 PMID: 17348802
10. Carreira AC, Lojudice FH, Halcsik E, Navarro RD, Sogayar MC, Granjeiro JM. Bone Morphogenetic Proteins: Facts, Challenges, and Future Perspectives. J Dent Res. 2014; 93(4):335-45. doi: 10.1177/0022034513518561 PMID: 24389809
11. Standal T, Abildgaard N, Fagerli U-M, Stordal B, Hjertner Ø, Borset M, et al. HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma. Blood. 2007; 109(7):3024-30. doi: 10.1182/blood-2006-07-034884 PMID: 17138824
12. Wen Q, Zhou L, Zhou C, Zhou M, Luo W, Ma L. Change in hepatocyte growth factor concentration promote mesenchymal stem cell-mediated osteogenic regeneration. J Cell Mol Med. 2012; 16(6):1260-73. doi: 10.1111/j.1582-4934.2011.01407.x PMID: 21831134; PubMed Central PMCID: PMCPMC3823079
13. Deschaseaux F, Sensébé L, Heymann D. Mechanisms of bone repair and regeneration. Trends Mol Med. 2009; 15(9):417-29. doi: 10.1016/j.molmed.2009.07.002 PMID: 19740701
14. Eom YW, Oh J-E, Lee JI, Baik SK, Rhee K-J, Shin HC, et al. The role of growth factors in maintenance of stemness in bone marrow-derived mesenchymal stem cells. Biochem Biophys Res commun. 2014; 445(1):16-22. doi: 10.1016/j.bbrc.2014.01.084 PMID: 24491556
15. Rosa A, Brivanlou AH. A regulatory circuitry comprised of miR-302 and the transcription factors OCT4 and NR2F2 regulates human embryonic stem cell differentiation. EMBO J. 2011; 30(2):237-48. doi: 10.1038/emboj.2010.319 PMID: 21151097; PubMed Central PMCID: PMCPMC3025464
16. Hu S, Wilson KD, Ghosh Z, Han L, Wang Y, Lan F, et al. MicroRNA-302 Increases Reprogramming Efficiency via Repression of NR2F2. Stem Cells. 2013; 31(2):259-68. doi: 10.1002/stem.1278 PMID: 23136034; PubMed Central PMCID: PMCPMC3572288
17. Hur S-W, Oh S-H, Jeong B-C, Choi H, Kim J-W, Lee K-N, et al. COUP-TFII Stimulates Dentin Sialophosphoprotein Expression and Mineralization in Odontoblasts. J Dent Res. 2015; 94(8):1135-42. doi: 10.1177/0022034515585125 PMID: 25940145
18. Turner N, Grose R. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer. 2010; 10(2):116-29. PMID: 20094046 doi: 10.1038/nrc2780
19. Frederick TJ, Min J, Altieri SC, Mitchell NE, Wood TL. Synergistic induction of cyclin D1 in oligodendrocyte progenitor cells by IGF-I and FGF-2 requires differential stimulation of multiple signaling pathways. Glia. 2007; 55(10):1011-22. doi: 10.1002/glia.20520 PMID: 17508424.
20. Choi S-C, Kim S-J, Choi J-H, Park C-Y, Shim W-J, Lim D-S. Fibroblast Growth Factor-2 and -4 Promote the Proliferation of Bone Marrow Mesenchymal Stem Cells by the Activation of the PI3K-Akt and ERK1/2 Signaling Pathways. Stem Cells Dev. 2008; 17(4):725-36. doi: 10.1089/scd.2007.0230 PMID: 18788932.
21. Kang HB, Kim JS, Kwon H-J, Nam KH, Youn HS, Sok D-E, et al. Basic Fibroblast Growth Factor Activates ERK and Induces c-Fos in Human Embryonic Stem Cell Line MizhES1. Stem Cells Dev. 2005; 14(4):395-401. doi: 10.1089/scd.2005.14.395 PMID: 16137228
22. Okazaki R, Ikeda K, Sakamoto A, Nakano T, Morimoto K, Kikuchi T, et al. Transcriptional activation of c-fos and c-jun protooncogenes by serum growth factors in osteoblast-like MC3T3-E1 cells. J Bone Miner Res. 1992; 7(10):1149-55. doi: 10.1002/jbmr.5650071006 PMID: 1456083
23. Ahn H-J, Lee W-J, Kwack K, Kwon YD. FGF2 stimulates the proliferation of human mesenchymal stem cells through the transient activation of JNK signaling. FEBS Lett. 2009; 583(17):2922-6. doi: 10.1016/j.febslet.2009.07.056 PMID: 19664626
24. Nakshatri H, Mendonca MS, Bhat-Nakshatri P, Patel NM, Goulet RJ Jr, Cornetta K. The Orphan Receptor COUP-TFII Regulates G2/M Progression of Breast Cancer Cells by Modulating the Expression/Activity of p21WAF1/CIP1, Cyclin D1, and cdk2. Biochem Biophys Res commun. 2000; 270(3):1144-53. doi: 10.1006/bbrc.2000.2562 PMID: 10772965
25. Chen X, Qin J, Cheng C-M, Tsai M-J, Tsai SY. COUP-TFII Is a Major Regulator of Cell Cycle and Notch Signaling Pathways. Mol Endocrinol. 2012; 26(8):1268-77. doi: 10.1210/me.2011-1305 PMID: 22734039; PubMed Central PMCID: PMCPMC3404301
26. Solchaga LA, Penick K, Goldberg VM, Caplan AI, Welter JF. Fibroblast Growth Factor-2 Enhances Proliferation and Delays Loss of Chondrogenic Potential in Human Adult Bone-Marrow-Derived Mesenchymal Stem Cells. Tissue Eng Pt A. 2009; 16(3):1009-19. doi: 10.1089/ten.tea.2009.0100 PMID: 19842915; PubMed Central PMCID: PMCPMC2862658
27. Kakudo N, Shimotsuma A, Kusumoto K. Fibroblast growth factor-2 stimulates adipogenic differentiation of human adipose-derived stem cells. Biochem Biophys Res commun. 2007; 359(2):239-44. doi: 10.1016/j.bbrc.2007.05.070 PMID: 17543283
28. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R. Fibroblast Growth Factor-2 Supports ex Vivo Expansion and Maintenance of Osteogenic Precursors from Human Bone Marrow. Endocrinology. 1997; 138(10):4456-62. doi: 10.1210/endo.138.10.5425 PMID: 9322963
29. Song T, Wang W, Xu J, Zhao D, Dong Q, Li L, et al. Fibroblast growth factor 2 inhibits bone morphogenetic protein 9-induced osteogenic differentiation of mesenchymal stem cells by repressing Smads signaling and subsequently reducing Smads dependent up-regulation of ALK1 and ALK2. Int J Biochem Cell Biol. 2013; 45(8):1639-46. doi: 10.1016/j.biocel.2013.05.005 PMID: 23680673
30. Byun MR, Kim AR, Hwang J-H, Kim KM, Hwang ES, Hong J-H. FGF2 stimulates osteogenic differentiation through ERK induced TAZ expression. Bone. 2014; 58:72-80. doi: 10.1016/j.bone.2013.09.024 PMID: 24125755
31. Lim S, Cho H, Lee E, Won Y, Kim C, Ahn W, et al. Osteogenic stimulation of human adipose-derived stem cells by pre-treatment with fibroblast growth factor 2. Cell Tissue Res. 2015:1-11. doi: 10.1007/s00441-015-2311-8 PMID: 26547859
32. Quarto N, Wan DC, Longaker MT. Molecular mechanisms of FGF-2 inhibitory activity in the osteogenic context of mouse adipose-derived stem cells (mASCs). Bone. 2008; 42(6):1040-52. doi: 10.1016/j.bone.2008.01.026 PMID: 18420480
33. Uhlik MT, Abell AN, Cuevas BD, Nakamura K, Johnson GL. Wiring diagrams of MAPK regulation by MEKK1, 2, and 3. Biochem Cell Biol. 2004; 82(6):658-63. doi: 10.1139/o04-114 PMID: 15674433
34. Cuevas BD, Abell AN, Johnson GL. Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene. 2007; 26(22):3159-71. PMID: 17496913
35. Qin J, Tsai SY, Tsai M-J. The critical roles of COUP-TFII in tumor progression and metastasis. Cell Biosci. 2014; 4:58. doi: 10.1186/2045-3701-4-58 PMID: 25328664; PubMed Central PMCID: PMCPMC4201699
36. El Agha E, Kosanovic D, Schermuly RT, Bellusci S. Role of fibroblast growth factors in organ regeneration and repair. Semin Cell Dev Biol. 2015. doi: 10.1016/j.semcdb.2015.10.009 PMID: 26459973
37. Di Maggio N, Mehrkens A, Papadimitropoulos A, Schaeren S, Heberer M, Banfi A, et al. Fibroblast Growth Factor-2 Maintains a Niche-Dependent Population of Self-Renewing Highly Potent Non-adherent Mesenchymal Progenitors Through FGFR2c. Stem Cells. 2012; 30(7):1455-64. doi: 10.1002/stem.1106 PMID: 22495904
38. Ito T, Sawada R, Fujiwara Y, Seyama Y, Tsuchiya T. FGF-2 suppresses cellular senescence of human mesenchymal stem cells by down-regulation of TGF-β2. Biochem Biophys Res commun. 2007; 359(1):108-14. doi: 10.1016/j.bbrc.2007.05.067 PMID: 17532297
39. Debiais F, Lefèvre G, Lemonnier J, Le Mée S, Lasmoles F, Mascarelli F, et al. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -β-catenin-independent signaling pathway. Exp Cell Res. 2004; 297(1):235-46. doi: 10.1016/j.yexcr.2004.03.032 PMID: 15194439
40. Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-Activated Protein Kinase: Conservation of a Three-Kinase Module From Yeast to Human. Physiol Rev. 1999; 79(1):143-80. PMID: 9922370
41. Kalajzic I, Kalajzic Z, Hurley MM, Lichtler AC, Rowe DW. Stage specific inhibition of osteoblast lineage differentiation by FGF2 and noggin. J Cell Biochem. 2003; 88(6):1168-76. doi: 10.1002/jcb.10459 PMID: 12647299
42. Lai W-T, Krishnappa V, Phinney DG. Fibroblast Growth Factor 2 (Fgf2) Inhibits Differentiation of Mesenchymal Stem Cells by Inducing Twist2 and Spry4, Blocking Extracellular Regulated Kinase Activation, and Altering Fgf Receptor Expression Levels. Stem Cells. 2011; 29(7):1102-11. doi: 10.1002/stem.661 PMID: 21608080; PubMed Central PMCID: PMCPMC3410557
43. Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, et al. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest. 2000; 105(8):1085-93. doi: 10.1172/JCI8641 PMID: 10772653; PubMed Central PMCID: PMCPMC300831
44. Kim S, Ahn C, Bong N, Choe S, Lee DK. Biphasic Effects of FGF2 on Adipogenesis. Plos One. 2015; 10(3):e0120073. doi: 10.1371/journal.pone.0120073 PMID: 25790378; PubMed Central PMCID: PMCPMC4366188
45. Debiais F, Hott M, Graulet AM, Marie PJ. The Effects of Fibroblast Growth Factor-2 on Human Neonatal Calvaria Osteoblastic Cells Are Differentiation Stage Specific. J Bone Miner Res. 1998; 13(4):645-54. doi: 10.1359/jbmr.1998.13.4.645 PMID: 9556064
46. Gastel vN, Stegen S, Stockmans I, Moermans K, Schrooten J, Graf D, et al. Expansion of Murine Periosteal Progenitor Cells with Fibroblast Growth Factor 2 Reveals an Intrinsic Endochondral Ossification Program Mediated by Bone Morphogenetic Protein 2. Stem Cells. 2014; 32(9):2407-18. doi: 10.1002/stem.1783 PMID: 24989687